# DETERA Therapeutics

> Rare kidney disease therapies

Business model and tags: Pharma & life sciences, Has in-house R&D

## About DETERA Therapeutics

Development of innovative therapies targeting rare kidney diseases to improve patient outcomes and address unmet medical needs.

## Key facts

- **Industry**: Biotechnology Research
- **Company size**: 1–10 employees
- **Founded**: 2024
- **Revenue**: $2.6M – $20.7M (Tamtam estimate)
- **Website**: [detera-therapeutics.com](https://www.detera-therapeutics.com/)
- **LinkedIn**: [linkedin.com/company/detera-therapeutics](https://www.linkedin.com/company/detera-therapeutics)

## DETERA Therapeutics at a glance

DETERA Therapeutics is a company in the Biotechnology Research industry.

DETERA Therapeutics was founded in 2024.

DETERA Therapeutics has 1–10 employees.

DETERA Therapeutics's revenue is $2.6M – $20.7M (Tamtam estimate).

## Frequently asked questions about DETERA Therapeutics

### What is DETERA Therapeutics's revenue?

Tamtam estimates DETERA Therapeutics's annual revenue at $2.6M – $20.7M.

### How many employees does DETERA Therapeutics have?

DETERA Therapeutics has 1–10 employees.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/detera-therapeutics